ConductScience.org, home

Paper42301302

Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

Kawazoe M and 14 others. Osteoporos Int, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial. Papers, record 42301302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42301302

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.
PubMed
Journal
Osteoporos Int
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawazoe MMaihttps://orcid.org/0000-0002-9822-8067
2Masuoka SShotaro
3Kaneko KKaichihttps://orcid.org/0000-0002-2082-6948
4Yamada ZZento
5Furukawa KKarin
6Watanabe EEri
7Koshiba KKeiko
8Yamada SSoichi
9Muraoka SSeihttps://orcid.org/0000-0002-9853-8057
10Sato HHiroshi
11Irita IIzumi
12Kanaji MMiwa
13Sugihara TTakahikohttps://orcid.org/0000-0002-7181-7494
14Nishio JJunko
15Nanki TToshihirohttps://orcid.org/0000-0002-3482-074X

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucocorticoidsMajor topic
DenosumabMajor topic
Bone Density Conservation AgentsMajor topic
OsteoporosisMajor topic
Antibodies, MonoclonalMajor topic
Humans
Female
Aged
Male
Bone Density
Drug Administration Schedule
Drug Therapy, Combination
Middle Aged
Prednisolone
Treatment Outcome
Rheumatic Diseases
Lumbar Vertebrae
Bridge Therapy
Risedronic Acid
Femur Neck
Diphosphonates

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JP 21K16665JSPS KAKENHIPubMed
No.19-19Project Research Grant from Toho University School of MedicinePubMed

Source PubMed

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125385412Glucocorticoid-induced osteoporosis: who to treat with what agent?Nat Rev Rheumatol2015https://conductscience.org/library/papers/25385412PubMed
212378366The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.Osteoporos Int2002https://conductscience.org/library/papers/12378366PubMed
324818875Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update.J Bone Miner Metab2014https://conductscience.org/library/papers/24818875PubMed
43165380Structure of the human liver/bone/kidney alkaline phosphatase gene.J Biol Chem1988https://conductscience.org/library/papers/3165380PubMed
531513250Efficacy and Safety of First- and Second-Line Drugs to Prevent Glucocorticoid-Induced Fractures.J Clin Endocrinol Metab2020https://conductscience.org/library/papers/31513250PubMed
638267664
Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
Osteoporos Int2024https://conductscience.org/library/papers/38267664PubMed
739387335Romosozumab versus denosumab in long-term users of glucocorticoids: A pilot randomized controlled trial.J Intern Med2024https://conductscience.org/library/papers/39387335PubMed
831214839The association of urinary pentosidine levels with the prevalence of osteoporotic fractures in postmenopausal women.J Bone Miner Metab2019https://conductscience.org/library/papers/31214839PubMed
921362762Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis.J Rheumatol2011https://conductscience.org/library/papers/21362762PubMed
1023788684Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial.J Clin Endocrinol Metab2013https://conductscience.org/library/papers/23788684PubMed
1118470669Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study.J Bone Miner Metab2008https://conductscience.org/library/papers/18470669PubMed
1239530312Pilot study of the effect of surgical menopause on bone mineral density and quality in patients with gynecological malignancies.J Obstet Gynaecol Res2025https://conductscience.org/library/papers/39530312PubMed
1310841167Use of oral corticosteroids and risk of fractures.J Bone Miner Res2000https://conductscience.org/library/papers/10841167PubMed
1426694595Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.Osteoporos Int2016https://conductscience.org/library/papers/26694595PubMed
1516937274Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen.J Bone Miner Metab2006https://conductscience.org/library/papers/16937274PubMed
1617566815Glucocorticoid-induced osteoporosis: pathophysiology and therapy.Osteoporos Int2007https://conductscience.org/library/papers/17566815PubMed
1712730746A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the Risedronate Late Phase II Research Group).Osteoporos Int2003https://conductscience.org/library/papers/12730746PubMed
1827273113Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis.Osteoporos Int2016https://conductscience.org/library/papers/27273113PubMed
1927641143Romosozumab Treatment in Postmenopausal Women with Osteoporosis.N Engl J Med2016https://conductscience.org/library/papers/27641143PubMed
2028551822Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.Clin Rheumatol2018https://conductscience.org/library/papers/28551822PubMed

See all 32 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42761068Case Report: Reopening the anabolic window - romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42761068

Source PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACP554PubTator's text mininghttps://conductscience.org/library/genes/54NCBI Gene
SOST50964PubTator's text mininghttps://conductscience.org/library/genes/50964NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42301302

GET https://conductscience.org/api/papers/v1/42301302/references?page=2